Loading...
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity
Blockade of immune checkpoint proteins (e.g., CTLA-4, PD-1) improves overall survival in advanced melanoma; however, therapeutic benefit is limited to only a subset of patients. Because checkpoint blockade acts by “removing the brakes” on effector T cells, the efficacy of checkpoint blockade may be...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5621898/ https://ncbi.nlm.nih.gov/pubmed/28931755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.93265 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|